Two 12-week phase 3 trials and a 43-week extension will test 8 mg and 16 mg HLP003 added to antidepressants, with APPROACH enrollment now complete.
|Articles|September 16, 2008
- April30 2004
- Volume 11
- Issue 8
Thumbs Up: Top Stocks
Advertisement
Fortune's
What stocks are the most admired?According to 2004 "America's Most Admired Companies"issue, here are the top 10respected stocks: Wal-Mart, BerkshireHathaway, Southwest Airlines, GeneralElectric, Dell Computer, Microsoft,Johnson & Johnson, Starbucks,FedEx, and IBM. Over the past 6 years,these 10 stocks have returned anaverage of 20% per year. The companiesrated as the nation's most financiallysound were UPS, Microsoft,Anheuser-Busch, and Exxon-Mobil.The companies rated as having thebest long-term investment valueswere ExxonMobil, UPS, BerkshireHathaway, and Newell Rubbermaid.
Articles in this issue
about 18 years ago
Observe Your Personal Finance Protocolabout 18 years ago
Win the Early Retirement Tax Challengeabout 18 years ago
Portfolio CHECK-UPabout 18 years ago
Close-Up: Moldabout 18 years ago
Finding Help to Treat Moldabout 18 years ago
Add Global Flair to Your Life Insuranceabout 18 years ago
Swing Away with the Fat-Pitch Approachabout 18 years ago
Don't Count on Social Security Benefitsabout 18 years ago
Doc's Stocks Contestabout 18 years ago
Know the ABC's of Mutual Fund InvestingAdvertisement
Related to this article
This preview of EADV 2026 provides a teaser of new data and interviews being highlighted at this Vienna dermatology conference.
Phase 2b AMPLIFIED data show a 42.7% UACR drop in AMKD with modest proteinuria; AMPLITUDE interim data are due early 2027.
Agusti, chair of the GOLD Board of Directors, discusses which COPD diagnostic bottleneck AI is closest to solving and more.
George Vasquez-Rios, MD, explains how the ASN's GD-C Compendium curates glomerular disease guidance for general clinicians and specialists alike.
Andrew Cutler, MD, says real-world MDD patients respond to adjunctive cariprazine like trial participants, with gains in mood and function within weeks.
Frances Lee, MD, on the stigma driving under-detection of ALD and its disproportionate rise in women and younger adults.
SOCS leaders explain SOCS Serves, a toolkit-based program connecting dermatology volunteers with students and underserved communities.
Advertisement
Advertisement
Trending on HCPLive
1
ProACt Data Show Early Functional Gains with Adjunctive Cariprazine In MDD
2
Half-Life vs. Real Life: How Real-World Evidence Is Reframing Wet AMD Treatment
3
How the ASN's GD-C Compendium Aims to Unify Glomerular Disease Care
4
DAPA-TRIO-HF: Dapagliflozin Improves HF Outcomes Regardless of Healthcare Setting
5